Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
05/31/2001 | CA2390923A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
05/31/2001 | CA2386955A1 Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes |
05/30/2001 | EP1103549A1 Photoprotective cosmetic compositions containing aminoamidine derivatives and uses thereof |
05/30/2001 | EP1103548A1 Triazolone derivatives, use thereof, and intermediate therefor |
05/30/2001 | EP1103547A1 Formazan metal complex |
05/30/2001 | EP1103544A2 Piperidine derivatives and antiplatelet agents containing the same |
05/30/2001 | EP1103261A1 Remedies or preventives for intractable epilepsy |
05/30/2001 | EP1103243A2 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of troubles mediated by an excess of substance p |
05/30/2001 | EP1102763A2 Fsh mimetics for the treatment of infertility |
05/30/2001 | EP1102762A2 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists |
05/30/2001 | EP1102756A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
05/30/2001 | EP1102754A1 Imidazoles and related compounds as alpha-1a agonists |
05/30/2001 | EP1102753A2 Pyrazoles as estrogen receptor modulators |
05/30/2001 | EP1102752A1 Succinoylamino lactams as inhibitors of a beta protein production |
05/30/2001 | EP1102750A1 Amide derivatives useful as inhibitors of the production of cytokines |
05/30/2001 | EP1102747A1 Crystalline forms of osanetant |
05/30/2001 | EP1102743A1 Amide derivatives which are useful as cytokine inhibitors |
05/30/2001 | EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors |
05/30/2001 | EP1102535A2 Compounds and methods |
05/30/2001 | EP0775133B1 Naphthalene amides having leukotriene-antagonistic action |
05/30/2001 | EP0665834B1 Quinolone and acridinone derivatives for the treatment of urinary incontinence |
05/30/2001 | EP0641320B1 Substituted (s)-3-phenylpiperidine derivatives, their preparation and their use as dopamine autoreceptor antagonists |
05/30/2001 | EP0637306B1 4-imidomethyl-1- [2'-phenyl-2'-oxoethyl]- piperidines as serotonin 5ht 2-antagonists, their preparation and use in therapy |
05/30/2001 | CN1297442A 5-aminoindeno [1,2-c] pyrazol-4-ones as anti-cancer and anti-proliferative agents |
05/30/2001 | CN1297441A Heterocyclically substd. amides used as calpain inhibitors |
05/30/2001 | CN1297440A Piperidinyl and N-amidinopiperidinyl derivs. |
05/30/2001 | CN1297438A Substd. indolinones having inhibiting effect on kinases and cycline/CDK complexes |
05/30/2001 | CN1297436A Substd. pyrrolidine hydroxamate metalloprotease inhibitors |
05/30/2001 | CN1066445C Aroyl-piperidine derivs. |
05/30/2001 | CN1066329C Preparation of drug composition |
05/30/2001 | CA2327026A1 Quinoline derivatives useful for inhibiting farnesyl protein transferase |
05/29/2001 | US6239306 Phenylsulfonylureas, processes for their preparation, and their use as herbicides and plant growth regulations |
05/29/2001 | US6239282 Alkylating the corresponding 3-amidothiophene compound |
05/29/2001 | US6239280 Oxidation the corresponsing thioimidazole compound |
05/29/2001 | US6239279 Therapy for cytokine sensitive diseases |
05/29/2001 | US6239175 Carbamoyloxy derivatives of mutiline and their use as antibacterials |
05/29/2001 | US6239164 Immunophilin affinity; nonimmunosuppressant |
05/29/2001 | US6239160 4-haloalkyl-3-heterocyclylpyridines and 4-haloalkyl-5-heterocyclylpyrimidines, processes for their preparation, compositions comprising them, and their use as pesticides |
05/29/2001 | US6239155 Phenyl-substituted 1,4-dihydropyridines |
05/29/2001 | US6239146 Neurotrophic difluoroamide agents |
05/29/2001 | US6239143 5-HT7 receptor antagonists |
05/29/2001 | US6239140 Compounds useful for inhibition of farnesyl protein transferase |
05/29/2001 | US6239135 Arylpiperazines having activity at the serotonin 1A receptor |
05/29/2001 | US6239131 1,5 Benzodiazepine derivatives |
05/29/2001 | US6239129 Characterised by an indole ring on the aromatic moiety by a cyano group and on the indole nitrogen by an aminoalkyl chain. great affinity for 5-ht2c receptors, useful for depression, panic attacks, obsessive-compulsive disorders, phobias, |
05/29/2001 | US6239127 Certain substituted caprolactams, pharmaceutical compositions containing them and a process for their preparation |
05/29/2001 | US6239125 Antiviral agents against herpes viruses. |
05/29/2001 | US6238689 Intestinal absorption of nicotine to treat nicotine responsive conditions |
05/29/2001 | CA2325783A1 Ultraviolet-protecting cosmetic compounds containing amino- amidine derivatives and uses |
05/29/2001 | CA2195923C Azetidines |
05/25/2001 | WO2001036660A2 Transition metal complexes attached to a polymer via a flexible chain |
05/25/2001 | WO2001036430A1 Transition metal complexes with bidentate ligand having an imidazole ring |
05/25/2001 | WO2001036413A1 Aryloxy propanolamines for improving livestock production |
05/25/2001 | WO2001036412A1 Process for the preparation of aryloxy propanolamines |
05/25/2001 | WO2001036411A1 Crystalline salts of (s)-4-(3-[n-(2-[4-(5-carbamoyl-2-pyridyloxy)phenyl]-1,1-dimethylethyl)amino]-2-hydroxypropoxy)indole |
05/25/2001 | WO2001036410A1 Herbicidal 2-aryloxy-6-fluoroalkylthioalk(en)yloxy-pyridine |
05/25/2001 | WO2001036409A1 Magnesium omeprazole |
05/25/2001 | WO2001036408A1 Compounds with antibacterial and antiparasitic properties |
05/25/2001 | WO2001036403A1 Urea derivatives as anti-inflammatory agents |
05/25/2001 | WO2001036395A1 Triazoles as farnesyl transferase inhibitors |
05/25/2001 | WO2001036390A1 Indazolyloxy propanolamines for improving livestock production |
05/25/2001 | WO2001036388A1 Aza compounds having neuronal activity |
05/25/2001 | WO2001035948A2 Neurophilin ligands for treating ocular conditions |
05/25/2001 | WO2001035739A1 Use of polysiloxanes containing quaternary amino groups as formulation auxiliary agents, and agents containing the same |
05/25/2001 | WO2001007433A3 Quinoline derivatives and their use as antibacterial agents |
05/25/2001 | WO2001007432A3 Aminopiperidine derivatives as antibacterials |
05/25/2001 | WO2000077027A3 Serine protease inhibitors |
05/25/2001 | WO2000039081A3 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
05/25/2001 | CA2391654A1 Aryloxy propanolamines for improving livestock production |
05/25/2001 | CA2391423A1 Polymeric transition metal complexes and uses thereof |
05/25/2001 | CA2391081A1 Herbicidal 2-aryloxy-6-fluoroalkylthioalk(en)yloxy-pyridine |
05/25/2001 | CA2390071A1 Aza compounds having neuronal activity |
05/25/2001 | CA2386579A1 Neurophilin ligands for treating ocular conditions |
05/23/2001 | EP1101765A2 Camptothecin analogues, process for their preparation and pharmaceutical compositions containing them |
05/23/2001 | EP1101764A1 Herbicidal 2-aryloxy-4-methyl-6-pyrazol-1-yl-pyridines |
05/23/2001 | EP1101763A2 Method for preparing sodium-hydrogen exchanger type 1 inhibitor |
05/23/2001 | EP1101757A1 Heterocyclic compounds as tachykinin receptor antagonists |
05/23/2001 | EP1100797A1 Heterocyclic compounds as inhibitors of rotamase enzymes |
05/23/2001 | EP1100795A1 Disubstituted bicyclic heterocycles having, in particular, a thrombin inhibitive effect |
05/23/2001 | EP1100794A1 COMPOUNDS SPECIFIC FOR THE HUMAN $g(a) 1d? ADRENERGIC RECEPTOR AND USES THEREOF |
05/23/2001 | EP1100786A1 Antiviral pyrimidinedione derivatives and process for the preparation thereof |
05/23/2001 | EP1100782A1 Amino-aldehyde solid support, linker therefor and methods of preparation and use thereof |
05/23/2001 | EP1100781A1 High affinity ligands for nociceptin receptor orl-1 |
05/23/2001 | EP1100779A1 Substituted indolinones, the production thereof and their use as medicaments |
05/23/2001 | EP1100763A1 Diketoacid-derivatives as inhibitors of polymerases |
05/23/2001 | EP1100519A1 Multibinding agents that modulate nmda receptors |
05/23/2001 | EP1100506A1 Integrin receptor antagonists |
05/23/2001 | EP1100504A2 Pharmaceutical compositions and their uses for treatment of demyelinating disorders |
05/23/2001 | EP1100485A1 Substituted anilide compounds and methods |
05/23/2001 | EP0900218A4 Heterocyclic compounds |
05/23/2001 | EP0779887B1 Novel benzimidazole derivatives having cgmp-phosphodiesterase inhibiting activity |
05/23/2001 | EP0750614B1 Quinazolinyl-amino derivatives having alpha-antagonist activity |
05/23/2001 | EP0689536B1 Naphthalene derivatives |
05/23/2001 | EP0680950B1 Propenone derivatives |
05/23/2001 | CN1296483A Febrifugine and isofebrifugine and processes for the preparation of both |
05/23/2001 | CN1296478A Histamine H3 receptor ligands |
05/23/2001 | CN1296475A Process for producing arylsulfenyl halide |
05/23/2001 | CN1296010A Novel cyano-indole thrombotonin reuptaking inhibitor compound, its preparation process and medicinal compositions having the same |
05/23/2001 | CN1066179C Azo dye mixture and use thereof |
05/23/2001 | CN1066145C N-substituted 3-azabicyclo (3,2,0) heptane derivatives and preparing method and use thereof |